IHH seeks RM5.5bil from Japan’s Daiichi for Fortis deal


PETALING JAYA: IHH Healthcare Bhd says its unit is seeking compensation of up to 109.3 billion rupees (RM5.46bil) from Japan’s Daiichi Sankyo for its stake buy in India’s Fortis Healthcare.

In October 2023, Northern TK Venture (NTK), a subsidiary of IHH Healthcare, had filed a claim against the Japanese pharmaceuticals manufacturer saying it caused losses to the company by preventing it from proceeding with open offers to buy a stake in Fortis Healthcare in 2018.

The company had initially claimed 20 billion yen (RM581.9mil) that Daiichi was ordered to pay as damages to NTK in November 2023.

After a report by an expert, NTK now claims compensation of between 4.24 billion rupees and 109.3 billion rupees.

IHH Healthcare, Asia’s largest healthcare group, had halted its open offer to buy an additional 26% stake in Fortis after Daiichi filed a contempt plea against Fortis founders, according to media reports.

Both Daiichi and Fortis did not immediately respond to a Reuters request for comment. — Reuters

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

OCBC to offer physical gold trading, storage in Singapore
Indonesia's FX reserves slide to two-year low, sparking concern�
US allegations of forced labor refuted
Chipmakers drag South Korea, Taiwan stocks lower as investors unwind AI bets
Liftech to raise RM23mil from ACE Market IPO
Yuan brushes off dollar strength, trade data eyed
Supply crisis to push costs beyond oil prices, whole-of-nation response needed
How a few AI chip giants warped Asia's stock picking game
Bursa Malaysia falls at midday as regional sell-off weighs
Sirim appoints Nik Sazali Nik Hussin as president and group CEO

Others Also Read